| December 22, 2003/ January 5, 2004 | |||||||||
In Print![]() Photo by Steve Gilbert
From Focus: For migraine patients, triptans are often the only drugs that provide relief. But their efficacy is inconsistent--in some patients they don't work at all, and in others they work only sometimes. Now Rami Burstein and colleagues report that they have identified a physiological mechanism distinguishing two groups of patients, one that always responds to the drugs and the other that responds only if the drugs are given early in an attack.
|
|
HeadlinesDefects in Trafficking Protein Linked to Reduced Brain Size and Mental Retardation
UpcomingMilestone Symposium Series:Stem Cells and Regenerative Medicine
Several presenters Lab WorksA multimedia site featuring Harvard Medical research |
Spotlight
Student Scene
|
||||||
Calendar | Jobs | Harvard Medical School Home | Hospitals | Back Issues | Feedback | Home |